Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone in Acute Exacerbation of Schizophrenia or Schizoaffective Disorder
NCT00645229Phase 3Terminated
- Sponsor
- Viatris
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ziprasidone in schizophrenia, schizoaffective disorder, sponsored by Viatris. Started Sep 2004; status: terminated.
02
Drugs
ziprasidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00645229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00645229.